Extracellular Vesicle-Associated Tissue Factor Activity in Prostate Cancer Patients with Disseminated Intravascular Coagulation.
disseminated intravascular coagulation
extracellular vesicles
peripheral blood mononuclear cells
platelets
prostate cancer
tissue factor
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
24 Mar 2021
24 Mar 2021
Historique:
received:
19
02
2021
revised:
05
03
2021
accepted:
15
03
2021
entrez:
3
4
2021
pubmed:
4
4
2021
medline:
4
4
2021
Statut:
epublish
Résumé
Patients with advanced prostate cancer may develop fulminant disseminated intravascular coagulation (DIC). Circulating extracellular vesicles (EVs)-exposing tissue factor (TF), the initiator of the coagulation cascade, may play an important role. We included 7 prostate cancer patients with DIC, 10 age- and stage-matched cancer controls without DIC, and 10 age-matched healthy male individuals. EV-TF activity was highly elevated in prostate cancer patients with DIC (11.40 pg/mL; range: 4.34-27.06) compared with prostate cancer patients without DIC (0.09 pg/mL; range: 0.00-0.30,
Identifiants
pubmed: 33804899
pii: cancers13071487
doi: 10.3390/cancers13071487
pmc: PMC8036918
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Austrian Science Fund
ID : SFB 54
Références
Thromb Haemost. 2009 Oct;102(4):728-34
pubmed: 19806259
Cancer Res. 1997 Jan 1;57(1):141-6
pubmed: 8988055
J Gen Intern Med. 2006 Nov;21(11):C6-8
pubmed: 17026724
Cancer. 1992 Aug 1;70(3):656-8
pubmed: 1623480
Blood. 1994 May 1;83(9):2516-25
pubmed: 7513203
Thromb Haemost. 2001 Nov;86(5):1327-30
pubmed: 11816725
Am J Pathol. 1989 May;134(5):1087-97
pubmed: 2719077
J Thromb Haemost. 2004 Nov;2(11):2065-7
pubmed: 15550054
Blood. 2005 Apr 1;105(7):2764-70
pubmed: 15604222
J Nucl Med. 1994 Oct;35(10):1662-4
pubmed: 7931669
Ann Hematol. 2008 Jun;87(6):451-7
pubmed: 18292996
Blood. 1993 Jul 15;82(2):513-20
pubmed: 8329706
Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):8767-71
pubmed: 7522321
J Am Coll Cardiol. 2001 Oct;38(4):1002-6
pubmed: 11583872
Thromb Res. 2013 Jul;132(1):112-5
pubmed: 23623171
Blood. 2000 Feb 1;95(3):930-5
pubmed: 10648405
Scand J Immunol. 2015 Dec;82(6):506-14
pubmed: 26332303
J Thromb Haemost. 2008 Nov;6(11):1983-5
pubmed: 18795992
Blood. 2012 May 3;119(18):4338-9; author reply 4339-41
pubmed: 22555664
Prog Clin Biol Res. 1976;6:313-27
pubmed: 66693
J Thromb Haemost. 2007 Mar;5(3):520-7
pubmed: 17166244
Circ Res. 2011 May 13;108(10):1284-97
pubmed: 21566224
Semin Oncol. 1992 Oct;19(5):580-96
pubmed: 1411655
Oncology. 2011;81(2):119-25
pubmed: 21986538
Hamostaseologie. 2014;34(1):54-62
pubmed: 24305775
Thromb Res. 2007;119(2):157-65
pubmed: 16527335
Arch Surg. 1973 Mar;106(3):295-8
pubmed: 4540187
Arterioscler Thromb Vasc Biol. 1997 Dec;17(12):3399-405
pubmed: 9437185
Urology. 1983 Aug;22(2):130-2
pubmed: 6879882
Blood. 1994 Mar 15;83(6):1535-41
pubmed: 7510145
Blood Coagul Fibrinolysis. 1994 Apr;5(2):211-20
pubmed: 8054453